INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹95 Cr | ₹155 Cr | ₹179 Cr | ₹174 Cr | ₹82 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹95 Cr |
| Mar2024 | ₹155 Cr |
| Mar2023 | ₹179 Cr |
| Mar2022 | ₹174 Cr |
| Mar2021 | ₹82 Cr |
How is Cash Flow from Operating Activities of INDOCO REMEDIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹95 Cr | -38.91 | |
| Mar2024 | ₹155 Cr | -13.11 | |
| Mar2023 | ₹179 Cr | 2.88 | |
| Mar2022 | ₹174 Cr | 111.41 | |
| Mar2021 | ₹82 Cr | - | |
Compare Cash Flow from Operating Activities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,002.9 Cr | -10.3% | -8.4% | -27.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -10.3% |
-8.4% |
-27.4% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses